3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
9
Polycystic Ovary Syndrome
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Obesity
5
Weight Loss
4
Neoplasms
4
Colonic Neoplasms
4
Prostatic Neoplasms
3
Endometrial Neoplasms
3
Overweight
2
Multiple Endocrine Neoplasia Type 1
2
Malnutrition
2
Lymphoma, Follicular
2
Carcinoma, Intraductal, Noninfiltrating
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcopenia
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Metabolic Syndrome
1
Menstruation Disturbances
1
Medical Oncology
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Standard of Care
18
Gemcitabine
18
Radiosurgery
14
Drug Therapy
13
Blood Specimen Collection
13
Endoscopic Ultrasound-Guided Fine Needle Aspiration
11
Exercise
10
Pancreaticoduodenectomy
9
Practice Guidelines as Topic
8
Methods
8
Magnetic Resonance Spectroscopy
8
Biopsy, Fine-Needle
8
Capecitabine
7
Early Intervention, Educational
6
Biopsy
6
Surveys and Questionnaires
5
Stents
5
Specimen Handling
5
Resistance Training
5
Radiofrequency Ablation
5
Psychiatric Rehabilitation
5
Oxaliplatin
5
Fluorouracil
5
Cholangiopancreatography, Endoscopic Retrograde
5
130-nm albumin-bound paclitaxel
5
Secretin
4
Radiotherapy
4
Irinotecan
4
Heavy Ion Radiotherapy
4
Electroporation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pancreatic Neoplasms
×
Diet
×
Clear all
NCT03187028
2021-11-18
PACE
University of Alabama at Birmingham
Phase NA
Completed
15 enrolled